Clinical trial
Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined…
NCT00197119 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00197119 |
|---|---|
| Title | Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years |
| Official title | Evaluate Persistence of Immune Response of GSK Biologicals' TWINRIX™ Vaccine Administered According to 0,6 Month Schedule Versus TWINRIX™ JUNIOR Administered According to 0,1,6 Month Schedule, in Subjects Aged 12-15 Years at Time of First Vaccine Dose |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis B, Hepatitis A |
| Intervention type | Biological |
| Interventions | Twinrix™ Adult, Twinrix™ Junior |
| Enrollment | 244 |
| Start date | May 1, 2004 |
| Primary completion | Jun 1, 2004 |
| Completion | Jun 1, 2004 |
| First posted | Sep 20, 2005 |
| Last update posted | Apr 20, 2017 |
| Countries | Belgium, Czechia |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: